Acuity Spatial Genomics, Inc. provides a ground-breaking platform designed for simultaneous, genome-wide visualization of the 3D genome in single cells and opens new frontiers in spatial multiomic analyses for discovery. Based on patented technologies developed at Harvard University, the company’s OligoFISSEQ and OligoFISSEQ HD technologies empower researchers to visualize the genome organization and 3D chromatin architecture of individual cells, directly in situ, and in an accessible time-to-result and cost-effective approach. The Acuity technology platform enables the possibility to delve deeper and gain critical insight into transcription regulatory programs that drive cell type, state, function, and pathogenesis—and thus advance discovery in areas such as oncology, neuroscience, and disease research. The company has facilities in Massachusetts and California.

Technology

Life Sciences

Biotechnology

Medical Devices

Acuity Spatial Genomics, Inc

Mark R. Munch

Suvarna Gandlur

Jude Dunne

Huy Nguyen

Brian Smart

The Leadership Team at Acuity Spatial Genomics, Inc. drives the strategic vision and operational execution of the company. Comprised of key executives such as the CEO, Chief Technology Officer & Co-founder, and Vice Presidents of various departments, this team oversees the development and commercialization of the company's groundbreaking spatial genomics technologies. They ensure alignment between scientific innovation, product development, and market strategies to advance research in oncology, neuroscience, and disease.

Leadership Team

Engineering and Research

Leadership Team

About

Team members

Other teams at Acuity Spatial Genomics, Inc

Engineering and Research